Found 7 matching trials
Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress
PHASE1The purpose of this study is to determine the safety, bioavailability, and ...
Location
University of Kentucky Alzheimer's Disease Research Center
Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD)
PHASE2The study aims to measure safety, tolerability and biomarker-based efficacy...
Status
Active Not Recruiting
Location
Sanos Clinic Gandrup
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
PHASE3This is a multicenter, randomized, placebo-controlled, 2-part study to eval...
Status
Active Not Recruiting
Location
Westside Medical Associates of Los Angeles
Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)
PHASE2The study aims to measure safety, tolerability and biomarker-based efficacy...
Status
Active Not Recruiting
Location
Landspitali University Hospital
Cardiovascular Effects of COVID-19
PHASE2Cardiometabolic disease may confer increased risk of adverse outcomes in CO...
Location
NYU Langone Health
Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer
PHASE1This phase Ib/II trial tests the safety and side effects of grapiprant and ...
Location
M D Anderson Cancer Center
AT-001 for Long-term Preservation of Brain Health in Aging
NAThe purpose of this study is to evaluate if the use of a yeast-selenium sup...
Location
University of Kentucky Sanders-Brown Center on Aging Clinic